Jones James bought CPIX
December 2, 2025 · Form 4 insider transaction
Jones James bought 18 shares of Cumberland Pharmaceuticals Inc. at $2.24 per share, a transaction worth $40.32. The trade was recorded as l under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 35 days after the transaction.
Direction
Acquired (buy-side)
Shares
18
Price
$2.24
Total value
$40.32
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeL: L
Transaction dateDecember 2, 2025
Filing dateJanuary 6, 2026
Shares owned after44,829
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.